{"SPADE_UN_15309": {"basic": {"SPADE ID": "SPADE_UN_15309", "Peptide Name": 17, "Sequence": "YXGFM", "Source": "Synthetic", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HBL (0.8% inhibition at 1μM, 1.4% inhibition at 10μM, 2.4% inhibition at 100μM, 18.3% inhibition at 1000μM); HEp-2 (1% inhibition at 1μM, 10.1% inhibition at 10μM, 16.8% inhibition at 100μM, 36.1% inhibition at 1000μM); SW620 (12.2% inhibition at 1μM, 15.5% inhibition at 10μM, 24.7% inhibition at 100μM, 29% inhibition at 1000μM); MCF-7 (22.8% inhibition at 1000μM); CaCo-2 (3% inhibition at 1μM, 8.4% inhibition at 10μM, 18.5% inhibition at 100μM, 10.6% inhibition at 1000μM); HT-29 (3.3% inhibition at 1μM, 11% inhibition at 10μM, 7.9% inhibition at 100μM, 23.7% inhibition at 1000μM); HeLa (4.9% inhibition at 1μM, 10.2% inhibition at 10μM, 13.3% inhibition at 100μM, 28% inhibition at 1000μM)", "Linear/Cyclic": "Linear", "Sequence Length": 5}, "extended_data_url": "SPADE_UN_15309_extended.json"}}